Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Biomira strengthens patent rights to Mucin 1 cancer antigen

Dec. 13, 1996

Positive phase IIa results for therapeutic vaccine for genital warts

Dec. 13, 1996

BioDelivery Sciences and Wyeth-Lederle Vaccines collaboration

Dec. 13, 1996

New immunostimulant from Snow Brand

Dec. 13, 1996

NAVA-Chiron Behring vaccine distribution agreement signed

Dec. 12, 1996

LG Chemical describes novel vaccine adjuvant formulation

Dec. 11, 1996

Oral influenza vaccine from Cortecs enters clinic

Dec. 4, 1996

AADA filed for generic ciclosporin

Dec. 3, 1996

Vasogen autocellular response therapy appears effective in RA

Nov. 29, 1996

Partners sought for 3DP MHC blockers

Nov. 29, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...